molecular cardiology

molecular cardiology

A popular term for the nascent branch of molecular medicine that seeks to translate discoveries made at the research bench in molecular biology into viable therapies for patients with cardiovascular disease.
Mentioned in ?
References in periodicals archive ?
After the propose three years, I expect to be ready to pursue an independent career in the field of molecular cardiology research.
Kapur, MD, Assistant Director of the Interventional Cardiology Center at Tufts Medical Center; Investigator at Tufts Molecular Cardiology Research Institute; and Assistant Professor at Tufts University School of Medicine, was a retrospective examination of demographic, hemodynamic, and laboratory data in 26 consecutive subjects treated with a 50 cc IABP and compared with 26 patients receiving a 40 cc IABP between 2012 and 2013.
And with contenders like "Tangled Up in Blue: Molecular Cardiology in the Postmolecular Era," and "Dietary Nitrate --a Slow Train Coming," the competition is fierce, if fiercely nerdy.
of Cardiology and the Sealy Center for Molecular Cardiology at the
2] Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, OH
of the Department of Molecular Cardiology at Cleveland Clinic's Lerner Research Institute, have discovered that the naturally occurring molecule Akt3 regulates lipid entry into macrophages and prevents the cells from storing excessive amounts of cholesterol and collecting in the artery.
We've studied this in rats, mice and pigs but this is the first time we've tried it in a human," said Roberto Bolli, director of UofL's Institute for Molecular Cardiology.
CV Therapeutics is a biopharmaceutical company focused on applying molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases.
The interim 18 month follow up results of the HEALING II study were presented on May 17, 2006 in Paris, France at the annual Paris Course on Revascularization (EuroPCR 2006) by Eric Duckers, MD, PhD, Head of Molecular Cardiology and Interventional Cardiologist at the Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
Interventional Cardiologist, Head of Molecular Cardiology, Thoraxcentre, Erasmus University Hospital and co-Principal Investigator for the trial, at the 7th International Symposium on Stem Cell Therapy & Cardiovascular Innovation in Madrid, Spain.
Marks, the Clyde and Helen Wu Professor of Molecular Cardiology (in Medicine), Chairman of the Department of Physiology and Cellular Biophysics, and Founding Director of the Clyde and Helen Wu Center for Molecular Cardiology at Columbia University Medical Center.
2] Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, OH

Full browser ?